Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00865345 · ClinicalTrials.gov registry record · NA
An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT00865345: Completed NA study, sponsored by Medtronic MiniMed.
NCT00865345 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00865345, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the performance of the subcutaneous glucose sensor over an extended sensor life. The sensor is currently approved for 3 days of use and this study will examine sensor safety and accuracy when used for six days. This study will also test sensor safety and accuracy when inserted in an alternate body location (buttock area in addition to abdomen area). The study hypothesis is that the sensor performance will not greatly diminish when used for six days, or in an alternate insertion area.
Interventions
- DEVICE MMT-7003 subcutaneous glucose sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00865345
The ClinicalTrials.gov registry entry for NCT00865345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MMT-7003 subcutaneous glucose sensor is the first listed.
NCT00865345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00865345 about?
NCT00865345 is a clinical study titled "An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance". The purpose of this study is to assess the performance of the subcutaneous glucose sensor over an extended sensor life. The sensor is currently approved for 3 days of use and this study will examine sensor safety and accuracy when used for six days. This study will also test sensor safety and accura...
What is the current status of trial NCT00865345?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2009-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00865345?
The interventions under investigation include: MMT-7003 subcutaneous glucose sensor (DEVICE).
Who is sponsoring clinical trial NCT00865345?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.